Prof. Yiqun Cao 曹依群
Chief Physician, Professor
Department of Neurosurgery, Fudan University Shanghai Cancer Center, Shanghai
Public profile Compiled from public listings and PubMed. We do not work directly with this doctor, but we can find a specialist in this field to review your case.
Get a specialist opinionClinical focus: Microsurgical treatment of brain tumors (glioma, pituitary adenoma, meningioma, acoustic neuroma, metastases) and spinal canal tumors (schwannoma, meningioma, intramedullary tumors, primary and metastatic spine tumors).
Dr. Cao holds a PhD in Neurosurgery and serves as Chief Physician and Professor at Fudan University Shanghai Cancer Center. With extensive clinical experience in nervous system and spinal tumors, Dr. Cao has published over 70 papers, including more than 10 SCI articles, and holds four patents. Research honors include the Second Prize for Military Scientific and Technological Progress.
Professional roles
- Vice Chair, Brain Metastasis Professional Committee, Shanghai Anti-Cancer Association
- Member, Spine and Spinal Cord Group, Neurosurgery Branch, Chinese Medical Association
- Member, Neurosurgery Professional Committee, China Anti-Aging Promotion Association
- Editorial Board Member, Surgical Oncology and Oncological Medicine
Name order: in Chinese the family name comes first (Cao Yiqun). Papers usually list the name as Yiqun Cao or Cao Y.
Selected publications
43 papers on PubMed matched by name and affiliation; 27 as first or senior author since 2016. Most recent first- or senior-author papers:
- J Transl Med, 2026 (senior author): Single-cell and spatial transcriptomes reveal oligodendrocyte remodeling fatty acid metabolism microenvironment of lung cancer brain metastases. PubMed 42304367
- Int J Biol Sci, 2026 (senior author): Oligodendrocyte-secreted ERBB3 Mediates the Competitive Uptake of Copper Ions by Tumor Cells to Promote Brain Metastasis in Lung Cancer. PubMed 42003929
- J Transl Med, 2026 (senior author): Clinical and immunological significance of tertiary lymphoid structure maturation heterogeneity in brain metastases of lung adenocarcinoma. PubMed 41691286
- Int J Surg, 2026 (senior author): New insight into the risk stratification and treatment priority of breast cancer: TMT scoring system. PubMed 41427575
- Cancer Commun (Lond), 2025 (senior author): HMGB3 promotes brain metastasis of lung adenocarcinoma by recruiting SSBP1 for nuclear translocation to remodel mitochondrial metabolism. PubMed 41194553
- Acta Biochim Biophys Sin (Shanghai), 2025 (senior author): The lncRNA DANCR promotes breast cancer brain metastasis by acting as a ceRNA for miR-758-3p to regulate PTGS2 expression. PubMed 40370195
- Int J Biol Sci, 2025 (senior author): SEC61G Facilitates Brain Metastases via Antagonizing PGAM1 Ubiquitination and Immune Microenvironment Remodeling in Non-Small Cell Lung Cancer. PubMed 39990664
- Acta Biochim Biophys Sin (Shanghai), 2024 (senior author): SEC61 translocon gamma subunit is correlated with glycolytic activity, epithelial mesenchymal transition and the immune suppressive phenotype of lung adenocarcinoma. PubMed 38978503
See the full PubMed search. Automatic matching can miss papers or include a namesake at the same hospital.
This profile has not been reviewed by the doctor. How we build this directory.
Want a specialist to review your case?
Send your records. We find a specialist in this field who can review your case and write a treatment plan with a cost estimate.
Get a specialist opinion